Stroke prevention in atrial fibrillation—An Asian stroke perspective

Tse, Hung‐Fat; Wang, Yong Jun; Ai-Abdullah, Moheeb Ahmed; Pizarro-Borromeo, Annette B.; Chiang, Chern‐En; Krittayaphong, Rungroj; Singh, Balbir; Vora, Amit; Wang, Chunxue; Zubaid, Mohammad; Clemens, Andreas; Lim, Paul; Hu, Dayi

doi:10.1016/j.hrthm.2013.03.017

Cited by 125 publications

(90 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…2 In Asia, the prevalence of AF has been reported to be slightly lower than that in Western populations. 3, 4 Due to the much larger population in Asia, the burden of AF is estimated to be much greater in Asian than in Western populations. Indeed, it has been estimated that in 2050 there will be 72 million patients with AF in Asia, 4 more than double the combined number of patients from Europe and the USA.…”

Section: Data Sourcesmentioning

confidence: 99%

Silent Cerebral Infarction in East Asian vs. Non-Asian Atrial Fibrillation Patients　― Meta-Analysis ―

Senoo

Kondo

Kobayashi

et al. 2018

Circ J

View full text Add to dashboard Cite

AF is also a well-established risk factor for dementia. For example, Liao et al reported a consistently higher rate of cognitive decline and risk of dementia in patients with AF. 11 These associations are partly due to the increased risk of clinical stroke in AF, but other mechanisms are likely to contribute, including the occurrence of SCI and microbleeds. 12 Current evidence is not sufficient to support a trend of increased prevalence of dementia in East Asia over the last few decades, but AF may contribute to dementia risk. We conducted a meta-analysis to compare the association of AF and SCI between East Asian and non-Asian patients. Methods Data SourcesPubMed were searched from their inception to 7 October 2017. No language restriction was applied. To ensure a comprehensive search of the literature, we also manually A trial fibrillation (AF) is the most common cardiac arrhythmia 1 and a major cause of stroke. The estimated global prevalence of AF is approximately 1-2%. 2 In Asia, the prevalence of AF has been reported to be slightly lower than that in Western populations. 3,4 Due to the much larger population in Asia, the burden of AF is estimated to be much greater in Asian than in Western populations. Indeed, it has been estimated that in 2050 there will be 72 million patients with AF in Asia, 4 more than double the combined number of patients from Europe and the USA. 1,5 Therefore, it is particularly important that AF is effectively managed in the ageing population of Asia.Silent cerebral infarction (SCI) is defined as the presence of cerebral infarction with the absence of corresponding clinical symptoms. In a recent meta-analysis, AF was associated with a more than 2-fold increased risk for SCI. 6 Several studies have reported an association between AF and increased risk of SCI in East Asian countries, 7-10 with the presence of SCI predicting subsequent clinically overt stroke. Thus, the prevalence of SCI and its effect as a risk factor for overt stroke are important considerations during the evaluation of AF.

show abstract

Section: Data Sourcesmentioning

confidence: 99%

Silent Cerebral Infarction in East Asian vs. Non-Asian Atrial Fibrillation Patients　― Meta-Analysis ―

Senoo

Kondo

Kobayashi

et al. 2018

Circ J

View full text Add to dashboard Cite

show abstract

“…4-11 Compared with the 5-fold higher likelihood of a stroke among Caucasian patients with AF than in those with sinus rhythm, 8 the stroke risk related to AF in Asians is typically lower (a relative risk of 3.70 in Japanese men). 4 In contrast, the relative risk of AFrelated mortality is comparable between Asian patients (1.88 in Japan) and Caucasians. 6 The risk of thromboembolic events in anticoagulated AF patients seems to be higher for Asians than Caucasians.…”

Section: Article P 2388mentioning

confidence: 98%

Thromboembolic Risks That Require Consideration for Antithrombotic Therapy in Japanese Patients With Atrial Fibrillation

Tada

2014

Circ J

View full text Add to dashboard Cite

“…Half of the world's population lives in Asia, and the elderly population in Asia has also increased rapidly [9]. Thus, the burden of atrial fibrillation in Asia is bound to become bigger than ever.…”

Section: Introductionmentioning

confidence: 99%

Translation and Validation of the Taiwanese Version of the Self-Efficacy for Appropriate Medication Use Scale

Chen¹,

Wang²

2017

OJN

View full text Add to dashboard Cite

Aims and objectives: To translate and validate a Taiwanese version of the Self-Efficacy for Appropriate Medication Use Scale (SEAMS). Background: The major barrier in the management of atrial fibrillation is the lack of selfefficacy to medications adherence. Patients' knowledge of the nature of atrial fibrillation and cardiovascular, cerebrovascular risk factors and anticoagulants is a significant factor affecting individuals' adherence. However, few instruments have been developed to assess patients' self-efficacy to medications adherence and none has been translated into Taiwanese. Design: This study used a standard ''forward-backward'' procedure, which was used to translate SEAMS into Taiwanese language. Reliability was tested for internal consistency. Validity was confirmed using criterion-related validity. Methods: Data collection for this research occurred from October 13, 2015 to October 26, 2016. The sample included atrial fibrillation outpatient. Participants simultaneously completed the Taiwanese version of the Self-Efficacy for Appropriate Medication Use Scale (SEAMS-T). A total of 151 individuals completed the questionnaire. Results: Coefficient alpha was 0.931 for atrial fibrillation patients. Conclusions: Findings provide support for the validity of the Taiwanese version of the Self-Efficacy for Appropriate Medication Use Scale (SEAMS-T). Relevance to clinical practice: The translation and validation of an instrument evaluating the self-efficacy for medication adherence in atrial fibrillation contribute to assessing the provided educational intervention.

show abstract

Stroke prevention in atrial fibrillation—An Asian stroke perspective

Cited by 125 publications

References 45 publications

Silent Cerebral Infarction in East Asian vs. Non-Asian Atrial Fibrillation Patients　― Meta-Analysis ―

Silent Cerebral Infarction in East Asian vs. Non-Asian Atrial Fibrillation Patients　― Meta-Analysis ―

Thromboembolic Risks That Require Consideration for Antithrombotic Therapy in Japanese Patients With Atrial Fibrillation

Translation and Validation of the Taiwanese Version of the Self-Efficacy for Appropriate Medication Use Scale

Contact Info

Product

Resources

About

Stroke prevention in atrial fibrillation—An Asian stroke perspective

Cited by 125 publications

References 45 publications

Silent Cerebral Infarction in East Asian vs. Non-Asian Atrial Fibrillation Patients ― Meta-Analysis ―

Silent Cerebral Infarction in East Asian vs. Non-Asian Atrial Fibrillation Patients ― Meta-Analysis ―

Thromboembolic Risks That Require Consideration for Antithrombotic Therapy in Japanese Patients With Atrial Fibrillation

Translation and Validation of the Taiwanese Version of the Self-Efficacy for Appropriate Medication Use Scale

Contact Info

Product

Resources

About

Silent Cerebral Infarction in East Asian vs. Non-Asian Atrial Fibrillation Patients　― Meta-Analysis ―

Silent Cerebral Infarction in East Asian vs. Non-Asian Atrial Fibrillation Patients　― Meta-Analysis ―